Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/30/10 → 7/30/13 |
Funding
- Boehringer Ingelheim Pharmaceuticals, Inc. (511.133)
Prot# 511.133: A Twenty-eight Week, Open-label, Safety, Extension Trial of Flibanserin 100 Milligrams Daily in Premenopausal and Naturally Postmenopausal Women with Hypoactive Sexual Desire in North America
- Stika, Catherine Susan (PD/PI)
- Dungan, Jeffrey S (Co-PD/PI)
- Luthringshausen, Michelle M (Co-PD/PI)
- Shulman, Lee P (Co-PD/PI)
- Tsai, Susan (Co-PD/PI)
Project: Research project